Company intelligence / Profile preview

Instituto Biológico Contemporáneo

Ituzaingó / Buenos Aires City* (*HQ registered at Chivilcoy 304, Capital Federal-Buenos Aires), Buenos Aires Province, Argentinaibclab.com.ar ↗

Ownership: Private
Development stage: Commercial

Overview

Instituto Biológico Contemporáneo specializes in the contract development and manufacturing of injectable medicines, including lyophilized products, sterile solutions, and sterile beta-lactam antibiotics. The company operates under GMP/GLP standards with international certifications such as MERCOSUR and INVIMA. It serves both national and international pharmaceutical markets.

Modalities: Small moleculeBiologic (for lyophilized products and sterile beta-lactam antibiotics)Injectable solution (as a dosage form)Lyophilized product (as a dosage form)Sterile beta-lactam powder (as a dosage form)
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Instituto Biológico Contemporáneo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Instituto Biológico Contemporáneo.

Explore the full profile